Cargando…

Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs

Sterols are constituents of the cellular membranes that are essential for their normal structure and function. In mammalian cells, cholesterol is the main sterol found in the various membranes. However, other sterols predominate in eukaryotic microorganisms such as fungi and protozoa. It is now well...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, Wanderley, Rodrigues, Juliany Cola Fernandes
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721973/
https://www.ncbi.nlm.nih.gov/pubmed/19680554
http://dx.doi.org/10.1155/2009/642502
_version_ 1782170265680084992
author de Souza, Wanderley
Rodrigues, Juliany Cola Fernandes
author_facet de Souza, Wanderley
Rodrigues, Juliany Cola Fernandes
author_sort de Souza, Wanderley
collection PubMed
description Sterols are constituents of the cellular membranes that are essential for their normal structure and function. In mammalian cells, cholesterol is the main sterol found in the various membranes. However, other sterols predominate in eukaryotic microorganisms such as fungi and protozoa. It is now well established that an important metabolic pathway in fungi and in members of the Trypanosomatidae family is one that produces a special class of sterols, including ergosterol, and other 24-methyl sterols, which are required for parasitic growth and viability, but are absent from mammalian host cells. Currently, there are several drugs that interfere with sterol biosynthesis (SB) that are in use to treat diseases such as high cholesterol in humans and fungal infections. In this review, we analyze the effects of drugs such as (a) statins, which act on the mevalonate pathway by inhibiting HMG-CoA reductase, (b) bisphosphonates, which interfere with the isoprenoid pathway in the step catalyzed by farnesyl diphosphate synthase, (c) zaragozic acids and quinuclidines, inhibitors of squalene synthase (SQS), which catalyzes the first committed step in sterol biosynthesis, (d) allylamines, inhibitors of squalene epoxidase, (e) azoles, which inhibit C14α-demethylase, and (f) azasterols, which inhibit Δ(24(25))-sterol methyltransferase (SMT). Inhibition of this last step appears to have high selectivity for fungi and trypanosomatids, since this enzyme is not found in mammalian cells. We review here the IC50 values of these various inhibitors, their effects on the growth of trypanosomatids (both in axenic cultures and in cell cultures), and their effects on protozoan structural organization (as evaluted by light and electron microscopy) and lipid composition. The results show that the mitochondrial membrane as well as the membrane lining the protozoan cell body and flagellum are the main targets. Probably as a consequence of these primary effects, other important changes take place in the organization of the kinetoplast DNA network and on the protozoan cell cycle. In addition, apoptosis-like and autophagic processes induced by several of the inhibitors tested led to parasite death.
format Text
id pubmed-2721973
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-27219732009-08-13 Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs de Souza, Wanderley Rodrigues, Juliany Cola Fernandes Interdiscip Perspect Infect Dis Review Article Sterols are constituents of the cellular membranes that are essential for their normal structure and function. In mammalian cells, cholesterol is the main sterol found in the various membranes. However, other sterols predominate in eukaryotic microorganisms such as fungi and protozoa. It is now well established that an important metabolic pathway in fungi and in members of the Trypanosomatidae family is one that produces a special class of sterols, including ergosterol, and other 24-methyl sterols, which are required for parasitic growth and viability, but are absent from mammalian host cells. Currently, there are several drugs that interfere with sterol biosynthesis (SB) that are in use to treat diseases such as high cholesterol in humans and fungal infections. In this review, we analyze the effects of drugs such as (a) statins, which act on the mevalonate pathway by inhibiting HMG-CoA reductase, (b) bisphosphonates, which interfere with the isoprenoid pathway in the step catalyzed by farnesyl diphosphate synthase, (c) zaragozic acids and quinuclidines, inhibitors of squalene synthase (SQS), which catalyzes the first committed step in sterol biosynthesis, (d) allylamines, inhibitors of squalene epoxidase, (e) azoles, which inhibit C14α-demethylase, and (f) azasterols, which inhibit Δ(24(25))-sterol methyltransferase (SMT). Inhibition of this last step appears to have high selectivity for fungi and trypanosomatids, since this enzyme is not found in mammalian cells. We review here the IC50 values of these various inhibitors, their effects on the growth of trypanosomatids (both in axenic cultures and in cell cultures), and their effects on protozoan structural organization (as evaluted by light and electron microscopy) and lipid composition. The results show that the mitochondrial membrane as well as the membrane lining the protozoan cell body and flagellum are the main targets. Probably as a consequence of these primary effects, other important changes take place in the organization of the kinetoplast DNA network and on the protozoan cell cycle. In addition, apoptosis-like and autophagic processes induced by several of the inhibitors tested led to parasite death. Hindawi Publishing Corporation 2009 2009-08-05 /pmc/articles/PMC2721973/ /pubmed/19680554 http://dx.doi.org/10.1155/2009/642502 Text en Copyright © 2009 W. de Souza and J. C. F. Rodrigues. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
de Souza, Wanderley
Rodrigues, Juliany Cola Fernandes
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs
title Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs
title_full Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs
title_fullStr Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs
title_full_unstemmed Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs
title_short Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs
title_sort sterol biosynthesis pathway as target for anti-trypanosomatid drugs
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721973/
https://www.ncbi.nlm.nih.gov/pubmed/19680554
http://dx.doi.org/10.1155/2009/642502
work_keys_str_mv AT desouzawanderley sterolbiosynthesispathwayastargetforantitrypanosomatiddrugs
AT rodriguesjulianycolafernandes sterolbiosynthesispathwayastargetforantitrypanosomatiddrugs